Lead-212 Radiopharmaceuticals for Receptor-Targeted Radionuclide Therapy
Receptor-targeted radionuclide therapy (RTRT) combines the power of particle-emitting radionuclides with the receptor-targeting capabilities of biomolecules, including antibodies and peptides. There are numerous radionuclides, but only a handful possess the necessary characteristics for targeted alp...
Saved in:
| Main Authors: | Solmaz Mojarad-Jabali, Sajjad Molavipordanjani |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Mazandaran University of Medical Sciences
2025-01-01
|
| Series: | Journal of Mazandaran University of Medical Sciences |
| Subjects: | |
| Online Access: | http://jmums.mazums.ac.ir/article-1-21231-en.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
212Pb in targeted radionuclide therapy: a review
by: Jarred Michael Scaffidi-Muta, et al.
Published: (2025-07-01) -
Adverse events associated with the use of radiopharmaceuticals: A prospective study from a tertiary care institute
by: Kanhaiyalal Agrawal, et al.
Published: (2025-04-01) -
Development of a methodology for the analysis of radionuclide impurities in radiopharmaceuticals by gamma-ray spectrometry
by: Eduardo Bonfim De Paula, et al.
Published: (2017-11-01) -
Gamma camera imaging characteristics of 203/212Pb as a theragnostic pair for targeted alpha therapy: a feasibility study
by: David Kästner, et al.
Published: (2025-05-01) -
Currents status of radiotracers for breast cancer imaging in PET
by: Chloé Jean, et al.
Published: (2025-03-01)